Real-time · AI · Cross-signal
WhiteHawk Capital Partners just moved. Here's exactly what to do next.
Who to reach, what to say, and why now — on WhiteHawk Capital Partners, plus every contract, funding round, and exec hire that follows. Verified, ICP-ranked contacts on demand (email + mobile).
Used by professionals at BlackRock, Oracle, Kleiner Perkins, HubSpot, and other leading firms — built on 10 years of proprietary signal data.
WhiteHawk Capital Partners Provides $350 million Credit Facility to Nephron Pharmaceuticals
Jan 10, 2025•over 1 year ago
Contract Type
partnership
Description
WhiteHawk Capital Partners, LP has entered into an agreement with Nephron Pharmaceuticals, LLC to provide a $350 million asset-based credit facility. Nephron will utilize the proceeds to support a recapitalization and liquidity for continued growth.
Agreement Insights
Based on industry dataStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months